54 452 (Lithium 300 mg)

Pill imprint 54 452 has been identified as Lithium carbonate 300 mg.

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; depression; schizoaffective disorder; cyclothymic disorder (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 54 452

Lithium carbonate 300 mg 54 452
Lithium carbonate 300 mg 54 452
Lithium carbonate 300 mg 54 452  Front
Lithium carbonate 300 mg 54 452  Back
Lithium carbonate
Imprint:
54 452
Strength:
300 mg
Color:
White
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Roxane Laboratories, Inc.
National Drug Code (NDC):
00054-4527
Inactive Ingredients:
calcium stearate
microcrystalline cellulose
povidone k29/32
sodium lauryl sulfate
sodium starch glycolate type A potato
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00054-8528 Roxane Laboratories,Inc.

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)